Abstract

Overweight and obesity is a growing global health concern. Current management of obesity includes lifestyle intervention, bariatric surgery and medication. The serotonin receptor, 5-HT2C, is known to mediate satiety, appetite and consumption behaviour. Lorcaserin, an appetite control drug, has demonstrated efficacy in appetite control by targeting 5-HT2C but causes undesirable side effects. This study aimed to explore the potential usage of Cassiae semen (CS), a well-known traditional Chinese medicine used to treat obesity. A computational molecular docking study was performed to determine the binding mechanism of CS compounds to the 5-HT2C receptors in both active, agonist-bound and inactive, antagonist-bound conformations. By comparing binding poses and predicted relative binding affinities towards the active or inactive forms of the receptor, we hypothesise that two of the CS compounds studied may be potent agonists which may mimic the appetite suppression effects of lorcaserin: obtusifoliol and cassiaside B2. Furthermore, two ligands, beta-sitosterol and juglanin, were predicted to bind favourably to 5-HT2C outside of the known agonist binding pocket in the active receptor, suggesting that such ligands may serve as positive allosteric modulators of 5-HT2C receptor function. Overall, this study proposed several CS compounds which may be responsible for exerting anti-obesity effects via appetite suppression by 5-HT2C receptor activation.

Highlights

  • Overweight and obesity are growing global health concerns [1]

  • The aim of this study is to evaluate the interactions of 5-HT2C receptor to the Cassiae semen (CS) ligands, and to propose the CS compounds responsible for exerting anti-obesity effects via appetite suppression

  • This study critically investigated the potential usage of Cassiae semen (CS), a well-known traditional Chinese medicine used to treat obesity

Read more

Summary

Introduction

Overweight and obesity are growing global health concerns [1]. In 2016, more than 1.9 billion adults aged 18 years and older were overweight, of which over 650 million adults were obese [2]. Weight gain involves excessive fat accumulation in the body, which is an important risk factor for cardiovascular disease (such as coronary heart disease, ischemic stroke and hypertension); type 2 diabetes; fatty liver disease; musculoskeletal disorders like osteoarthritis and certain types of cancers (such as endometrial, breast and colon). These conditions may cause premature death and substantial disability [3,4,5]. Bariatric surgery is an effective way to lose excess weight, it is usually offered to people who are very obese with a body mass index (BMI) over 40 or people with a BMI over 35 who have other serious health conditions, such as diabetes or heart disease [10]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call